These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 35281843)

  • 21. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
    Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
    Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model.
    Liang S; Qiu X; Cai L; Wei F; Huang J; Liu S
    Transl Cancer Res; 2024 Jul; 13(7):3704-3717. PubMed ID: 39145089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression levels of S1PR3 and PDGFRB indicates unfavorable clinical outcomes in colon adenocarcinoma.
    Yu M; Zhang K; Wang S
    Heliyon; 2024 Aug; 10(15):e35532. PubMed ID: 39170287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
    Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
    Front Genet; 2023; 14():1098190. PubMed ID: 37274780
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
    Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
    Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
    Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
    Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

  • 32. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
    Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
    Front Genet; 2022; 13():821826. PubMed ID: 35664320
    [No Abstract]   [Full Text] [Related]  

  • 33. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma.
    Fu X; Duanmu J; Li T; Jiang Q
    PeerJ; 2020; 8():e8877. PubMed ID: 32309045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients.
    JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T
    Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An innovative prognostic auxiliary for colon adenocarcinoma based on zinc finger protein genes.
    Xu F; Sun J; Gu X; Zhou Q
    Transl Cancer Res; 2024 Apr; 13(4):1623-1641. PubMed ID: 38737696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma.
    Zhang J; Liu Z; Chen W; Liu H
    Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma.
    Zhou R; Sun Z; Zhou R; Wang M; Zhuo Q; Deng X; Wang Z; Xu Y
    Med Oncol; 2024 Oct; 41(11):285. PubMed ID: 39402288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma.
    Sun Z; Wang H; Xu Y; Liu Y; Wang L; Zhou R; Zhou R; Ma W; Zhang T
    J Gastrointest Oncol; 2024 Apr; 15(2):641-667. PubMed ID: 38756632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
    Gao H; Xing F
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.